CHICAGO—The Chicago Tribune is reporting that Baxter International, Inc., may face multiple lawsuits stemming from its 2008 voluntary recall of heparin that led to allergic reactions and death. The paper cited a law firm that said as many as 300 product-liability complaints may be filed in Illinois state courts.
The U.S. Food and Drug Administration (FDA) requested new manufacturing standards for the blood thinner in 2008 after problems were linked to tainted ingredients from China. The complaints accuse Baxter and the supplier, Scientific Protein Laboratories, of negligence, alleging their products were unsafe for their intended use.
